APP Pharmaceuticals Launches Rocuronium Bromide Injection (Medical News Today) |
![]() |
APP Pharmaceuticals, Inc., a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced that it has launched Rocuronium Bromide Injection, the generic equivalent of Organon's Zemuron®. |